Skip To Content

Study ID: Incyte BMS INCB24360-204 Advanced Tumors

Title:

A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Select Advanced Cancers

Location:
Fargo Region, Sioux Falls Region
Principal Investigator:
Steven Powell, MD,Amit Panwalkar, MD
Disease:
Other, NHL (Non-Hodgkins Lymphoma)
Stage:
Phase I/II
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.